Back to CVE records
High 8.8Published Oct 20, 2026

CVE-2026-101594Vulnerability in the Oracle Agile Product Lifecycle Management for Process product of Oracle Supply Chain (component: Product Quality Management).

Updated under an hour ago ()

Does this affect you?

It affects Oracle Corporation Oracle Agile Product Lifecycle Management for Process. Add what you run to find out whether that includes you.

EPSS puts the chance of exploitation in the next 30 days at 0.45%, higher than 38% of scored CVEs.

Vulnerability in the Oracle Agile Product Lifecycle Management for Process product of Oracle Supply Chain (component: Product Quality Management). The supported version that is affected is 6.2.4. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Agile Product Lifecycle Management for Process. Successful attacks of this vulnerability can result in takeover of Oracle Agile Product Lifecycle Management for Process. CVSS 3.1 Base Score 8.8 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H).

CVSS
8.8 HIGH (v3.1, CNA)CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
Weakness (CWE)
Not given
Known exploited
Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days)
0.45% (percentile 38)
Assigned by
oracle
NVD analysis
Awaiting Analysis
Record last updated
Oct 20, 2026
First seen by InfoSec Signals
Oct 20, 2026

Affected products

Affected products
Oracle Corporation Oracle Agile Product Lifecycle Management for Process
oracle:agile_product_lifecycle_management_for_process (from the name)
6.2.4
CNA record

References

References

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.